These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18295249)

  • 1. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
    Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
    J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
    Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
    Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
    Bro S
    Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
    Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
    Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis.
    Chen MS; Xu FP; Wang YZ; Zhang GP; Yi Q; Zhang HQ; Luo JD
    J Mol Cell Cardiol; 2004 Oct; 37(4):889-96. PubMed ID: 15380679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin causes the formation of cholesterol-rich remnants in mice lacking apoE.
    Fu T; Borensztajn J
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1172-6. PubMed ID: 16460674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification.
    Maizel J; Six I; Slama M; Tribouilloy C; Sevestre H; Poirot S; Giummelly P; Atkinson J; Choukroun G; Andrejak M; Kamel S; Mazière JC; Massy ZA
    Circulation; 2009 Jan; 119(2):306-13. PubMed ID: 19118252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
    Ivanovski O; Nikolov IG; Joki N; Caudrillier A; Phan O; Mentaverri R; Maizel J; Hamada Y; Nguyen-Khoa T; Fukagawa M; Kamel S; Lacour B; Drüeke TB; Massy ZA
    Atherosclerosis; 2009 Jul; 205(1):55-62. PubMed ID: 19118829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice.
    Zeadin M; Butcher M; Werstuck G; Khan M; Yee CK; Shaughnessy SG
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2069-75. PubMed ID: 19797706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease.
    Wu B; Elmariah S; Kaplan FS; Cheng G; Mohler ER
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):592-7. PubMed ID: 15618546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
    Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
    Mikael LG; Rozen R
    Cardiovasc Res; 2008 Oct; 80(1):151-8. PubMed ID: 18540024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a statin vs. hypolipemic diet on the oxidant status in hemodialyzed patients with chronic renal failure.
    Mastalerz-Migas A; Reksa D; Pokorski M; Steciwko A; Muszyńska A; Bunio A; Drobnik J; Pokorna-Kałwak D
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):363-70. PubMed ID: 18204148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.
    Luo L; Zheng YF; Dai Y; Dai DZ
    J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.